Dirk Kersten sold $2.8M of Dyne Therapeutics (DYN)

Executed Sep 19 2024, disclosed Sep 20 2024, 1 day later.

Value, as filed

$2.8M

78,739 sh across 2 lots

Executed

Sep 19 2024

the trade date, as filed

Disclosed

Sep 20 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Dirk Kersten Director profile →

Dirk Kersten (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Dyne Therapeutics, Inc. (DYN). The largest single filing was $13.2M of DYN (688,788 sh across 4 lots, as filed), executed Mar 9.

The name

DYN

Dyne Therapeutics, Inc. DYN · Healthcare · 31 filings in 24 months ticker →

Healthcare · Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscul…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Dirk Kersten in DYN

DYNSALE Dyne Therapeutics, Inc. $6.7M
261,460 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 4:15 PM ET DYNSALE Dyne Therapeutics, Inc. $5.4M
262,305 sh across 2 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $1.7M
84,355 sh across 2 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $166K
8,300 sh × $20.01
Exec Apr 21
Filed Apr 23 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $6.8M
337,248 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $2.0M
99,613 sh across 3 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $2.5M
129,672 sh × $19.52
Exec Mar 11
Filed Mar 13 · 5:30 PM ET DYNSALE Dyne Therapeutics, Inc. $13.2M
688,788 sh across 4 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET